Patient outcomes platform will improve clinical development, says ICON
ICON and the International Consortium for Health Outcomes Measurement's (ICHOM) pilot patient outcomes platform – known as ‘Globe’ – aims to improve drug development procedures.
ICON and the International Consortium for Health Outcomes Measurement's (ICHOM) pilot patient outcomes platform – known as ‘Globe’ – aims to improve drug development procedures.
AMRI’s SSCI has announced the availability of in vitro bioequivalence testing services, as more products entering the market require laboratory-based testing.
CPHI WORLDWIDE 2017
Quintiles IMS’ Alan Shephard says manufacturing cost transparency will reduce criticism surrounding generics pricing, but one association believes this will lead to anti-competitive behaviour among drugmakers.
Clinical trials conducted outside of India – which test drugs for the Indian market – must include Indian subjects, according to a ruling in India last month.
Parexel has augmented its active tracking service with in-pack wireless sensors to monitor temperature-sensitive medications from packaging to patient dispensation.
The US FDA has sent a warning letter to Kim Chemicals Private Ltd after finding GMP issues at its facility in Raigad, Maharashtra.
Pfizer has attributed a 12% operational decline from its sterile injectable products on “capacity constraints and technical issues” stemming from former Hospira facilities.
The US FDA says the recognition of facility inspections from eight European regulatory authorities is an “unprecedented and significant step forward” in the transatlantic Mutual Recognition Agreement.